Innovations in biomedical engineering at CU Boulder involve layering polymers to support the growth of essential cells for long-term vessel health. Cardiovascular diseases remain a critical global threat, claiming approximately 20 million lives annually and necessitating advanced surgical
By inducing the lysis of malignant cells, oncolytic viruses release a broad spectrum of neoantigens that can prime a patient’s native immune system through a process called epitope spreading. This mechanism represents a significant shift from the current clinical standard of single-target Chimeric
The oncology sector is shifting its primary focus from simply managing terminal disease to achieving functional cures that allow patients to live long, healthy lives. This transition marks a departure from the historical reliance on broad-spectrum treatments that often came with debilitating side
The development of a connected nationwide ecosystem for cellular therapy is designed to standardize the quality of regenerative care across every Malaysian state. This ambitious shift is currently reshaping the biotechnology sector, where the focus has moved from being a passive consumer of
The inherent inefficiencies of the autologous model are tied to a one-batch-per-patient approach that restricts throughput and maintains high market prices for oncology treatments. While Chimeric Antigen Receptor (CAR) T-cell therapies have redefined oncology by providing life-saving results for
The ability to detect regulatory signals in rare cell states provides a functional hypothesis-generating resource for prioritizing causal variants in large-scale genetic studies. Scientists have long observed that two individuals of similar age and health can experience radically different outcomes
